Purpose
to evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule
Grantee
Division
Global Health
Date
MARCH 2015
Region served
GLOBAL
Committed amount
$1,197,569
Grant topic
Pneumonia
Duration (months)
46
Grantee location
London, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.